Related content

Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?

By Maru Dipen M.   Agarwal Atin A.   Hu Chung-Yuan   Chang George J.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1282-1282

Blackwell Publishing

Access to resources Recommend Favorite

Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?

By You Kai Yun   Gao Yuan Hong  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1281-1282

Blackwell Publishing

Access to resources Recommend Favorite

Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin

By Gordon Michael A   Zhang Wu   Yang Dongyun   Iqbal Syma   El-Khouiery Anthony   Nagashima Fumio   Lurje Georg   Labonte Melissa   Wilson Peter   Sherrod Andy   Ladner Robert D   Lenz Heinz-Josef  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 27-39

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response

By Balboa Emilia   Duran Goretti   Lamas Maria Jesus   Gomez-Caamaño Antonio   Celeiro-Muñoz Catuxa   Lopez Rafael   Carracedo Angel   Barros Francisco  

Pharmacogenomics, Vol. 11, Iss. 6, 2010-06 ,pp. : 747-761

Future Medicine

Access to resources Recommend Favorite

Glutathione S-Transferase P1 Ile105Val Polymorphism is Associated with Haematological Toxicity in Elderly Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy

By Agostini Marco  

Drugs & Aging, Vol. 25, Iss. 6, 2008-01 ,pp. : 531-539

Adis International

Access to resources Recommend Favorite